Skip to main content
. 2019 Nov 27;20:39–44. doi: 10.1016/j.ctro.2019.11.003

Table 1.

Patients, tumor and treatment characteristics, stratified by tumor regression grade (TRG).

Total
N = 94 (%)
TRG 1–2
N = 42 (%)
TRG 3–5
N = 52 (%)

P-value
Gender
 Male 71 (76) 28 (67) 43 (83) 0.07
 Female 23 (25) 14 (33) 9 (17)
Median age (years)[range] 64 [25–82] 64 [39–74] 65 [25–82] 0.69
Weight loss at presentation
 None 29 (31) 18 (43) 11 (21) 0.06
 ≤10% 42 (45) 14 (33) 28 (54)
 ˃10% 23 (25) 10 (24) 13 (25)
Alcohol consumption
 None or stopped 28 (30) 14 (33) 14 (27) 0.78
 Yes 64 (68) 27 (64) 37 (71)
 Unknown 2 (2) 1 (2) 1 (2)
Smoking
 Never or stopped 57 (61) 25 (60) 32 (62) 0.63
 Yes 36 (38) 17 (41) 19 (37)
 Unknown 1 (1) 0 (0) 1 (2)
Tumor location
 GEJ 11 (12) 3 (7) 8 (15) 0.46
 Middle 9 (10) 4 (10) 5 (10)
 Low 74 (79) 35 (83) 39 (75)
Median length tumora(cm) [range] 5 [1–11] 5 [2–11] 6 [1–10] 0.53
Histology
 Adenocarcinoma 75 (80) 32 (76) 43 (83) 0.44
 Squamous cell carcinoma 19 (20) 10 (24) 9 (17)
Cycles of chemotherapy
 <5 cycles 13 (14) 4 (10) 9 (17) 0.28
 5 cycles 81 (86) 38 (91) 43 (83)
Median time interval between nCRT and surgery (days)[range] 44 [25–85] 43 [25–58] 47 [31–85] 0.12
cT status
 cT2 16 (17) 7 (20) 9 (6) 0.84
 cT3 72 (77) 33 (74) 39 (89)
 cTx 6 (6) 2 (7) 4 (6)
cN status
 cN0 23 (25) 8 (19) 15 (29) 0.48
 cN1 42 (45) 19 (45) 23 (44)
 cN2 28 (30) 14 (33) 14 (27)
 cN3 1 (1) 1 (2) 0 (0)
Differentiation grade
 Well/Moderate 44 (47) 20 (48) 24 (47) 0.98
 Poor 50 (53) 22 (52) 28 (53)

Abbreviations: GEJ: Gastro-esophageal junction.

a

Tumor length was determined by endoscopy. If tumor length by endoscopy was not reported, tumor length on CT scan was used instead.